Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo
BioMarin Pharmaceutical Australia Pty Ltd
Mucopolysaccharidosis VI
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Placebo
Takeda
Hypoparathyroidism
1 trial -
Placebo
AstraZeneca
Irritable Bowel Syndrome With Constipation (IBS-C)
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Schizophrenia
2 trials -
Placebo
Takeda
Short Bowel Syndrome
1 trial -
Placebo
SUPERNUS PHARMACEUTICALS, INC.
ADHD
5 trials -
Placebo
Mineralys Therapeutics
Hypertension
2 trials -
Placebo
Hoffmann-La Roche
Schizophrenia
1 trial -
Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Schizoaffective Disorder
1 trial -
Placebo
Biogen
Multiple Sclerosis, Remittent Progressive
1 trial -
Placebo
Boehringer Ingelheim
Diabetes Mellitus, Type 2
3 trials -
Placebo
Sanofi Pasteur
Colorectal Neoplasms
1 trial -
Placebo
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
1 trial -
Placebo
Pfizer
Ulcerative Colitis
1 trial -
Placebo
Takeda
Lennox Gastaut Syndrome (LGS)
1 trial -
Placebo
Menarini Group
Acute Pain
1 trial -
Placebo
Takeda
Generalized Anxiety Disorder
1 trial -
Placebo
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Placebo
Novartis Pharmaceuticals
IC-MPGN
1 trial -
Placebo
Allergan Pharmaceuticals International Limited
Gastroparesis
3 trials -
Placebo
Amgen
Breast Cancer
1 trial -
Placebo
Takeda
Male Subjects With Chronic Constipation
1 trial -
Placebo
Jazz Pharmaceuticals Ireland Limited
Palliative Care
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.